Cargando…

Beta-amyloidolysis and glutathione in Alzheimer’s disease

In this review, we hypothesized the importance of the interaction between the brain glutathione (GSH) system, the proteolytic tissue plasminogen activator (t-PA)/plasminogen/ plasmin system, regulated by plasminogen activator inhibitor (PAI-1), and neuroserpin in the pathogenesis of Alzheimer’s dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasierra-Cirujeda, J, Coronel, P, Aza, MJ, Gimeno, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Expert Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640603/ https://www.ncbi.nlm.nih.gov/pubmed/23650462 http://dx.doi.org/10.2147/JBM.S35496

Ejemplares similares

Use of sulodexide in patients with peripheral vascular disease
por: Lasierra-Cirujeda, J, et al.
Publicado: (2010)

Update on the use of memantine in Alzheimer’s disease
por: van Marum, Robert J
Publicado: (2009)

Rivastigmine in the treatment of patients with Alzheimer’s disease
por: Müller, Thomas
Publicado: (2007)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Donepezil in Alzheimer’s disease: From conventional trials to pharmacogenetics
por: Cacabelos, Ramón
Publicado: (2007)

Alzheimer’s Disease – Why We Need Early Diagnosis
por: Rasmussen, Jill, et al.
Publicado: (2019)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)

Updates in pulmonary hypertension and other pulmonary vascular diseases
por: Bernardo, Roberto J., et al.
Publicado: (2019)

Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease?
por: Finney, Lydia J.
Publicado: (2019)

Early Career Members at the ERS Lung Science Conference: cell-matrix interactions in lung disease and regeneration: Early career forum
por: Almendros, Isaac, et al.
Publicado: (2018)

Degos disease – malignant atrophic papulosis or cutaneointestinal lethal syndrome: rarity of the disease
por: Pirolla, Eduardo, et al.
Publicado: (2015)

Secondary pneumothorax in end-stage lung disease complicated by noninvasive ventilation and a persistent air leak
por: McCracken, David J., et al.
Publicado: (2018)

Expert Opinion Guidance on the Detection of Early Connective Tissue Diseases in Interstitial Lung Disease
por: Namas, Rajaie, et al.
Publicado: (2023)

Rasagiline in treatment of Parkinson’s disease
por: Nayak, Lakshmi, et al.
Publicado: (2008)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Betahistine in the treatment of Ménière’s disease
por: Lacour, Michel, et al.
Publicado: (2007)

An unusual disease with an interesting sign
por: Afthinos, Andreas, et al.
Publicado: (2020)

A disease with many faces
por: Caires, Nídia, et al.
Publicado: (2019)

How to carry out a field walking test in chronic respiratory disease
por: Holland, Anne E., et al.
Publicado: (2015)

Early Career Members at the ERS Lung Science Conference 2020: metabolic alterations in lung ageing and disease
por: Ogger, Patricia P., et al.
Publicado: (2020)

Continuous levodopa for advanced Parkinson’s disease
por: Lundqvist, Christofer
Publicado: (2007)

Update on ropinirole in the treatment of Parkinson’s disease
por: Shill, Holly A, et al.
Publicado: (2009)

Assembly 12: interstitial lung diseases
por: Antoniou, Katerina, et al.
Publicado: (2018)

Autoantibody Profiles in Autoimmune Rheumatic Diseases
por: Bizzaro, Nicola
Publicado: (2019)

Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: implications from a clinical and patient perspective
por: Brooks, David J
Publicado: (2008)

Egyptian Consensus on the Role of Lung Ultrasonography During the Coronavirus Disease 2019 Pandemic
por: Zaky, Samy, et al.
Publicado: (2022)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Rivastigmine for the treatment of dementia associated with Parkinson’s disease
por: Reingold, Jennifer L, et al.
Publicado: (2007)

Assembly 5: airway diseases: Meet the Assemblies
por: Spanevello, Antonio
Publicado: (2017)

Cell-Based Regenerative Therapy as an Alternative to Liver Transplantation for End-Stage Liver Disease: Experience from Iran
por: Malekzadeh, R., et al.
Publicado: (2010)

An unusual presentation of a more common disease entity
por: Van de Kerkhove, Charlotte, et al.
Publicado: (2018)

Choosing pharmacotherapy for ILD in patients with connective tissue disease
por: Wu, Zhe, et al.
Publicado: (2021)

A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
por: Rodriguez-Garcia, Alejandro, et al.
Publicado: (2022)

Clues beyond the lung: an unusual diagnosis in an infant with chronic lung disease
por: Walsh, Rachel, et al.
Publicado: (2020)

Contribution of causal factors to disease burden: how to interpret attributable fractions
por: Counil, Emilie
Publicado: (2021)

A 43-year-old patient presenting with marked eosinophilia and multisystem disease
por: Panjwani, Amit, et al.
Publicado: (2016)

Toward more focused multimodal and multidisciplinary approaches for pain management in Parkinson’s disease
por: Cuomo, Arturo, et al.
Publicado: (2019)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson’s disease: implications for patients
por: Antonini, Angelo, et al.
Publicado: (2011)

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People’s Republic of China
por: Cai, Bai-qiang, et al.
Publicado: (2014)

Landmark papers in respiratory medicine: Automatic quantification of emphysema and airways disease on computed tomography
por: Mohamed Hoesein, Firdaus A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1vuela32fh024r1gvf2m4ett67